Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases-INVITATION Trial.

CONCLUSIONS: This study could not demonstrate the superiority of appropriate-dose of rosuvastatin in inhibiting serum MMPs levels in patients with AMI. PMID: 33408315 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33408315?dopt=Abstract

Source: Journal of Atherosclerosis and Thrombosis - January 9, 2021 Category: Cardiology Tags: J Atheroscler Thromb Source Type: research